Author:
Soen Satoshi,Kishimoto Hideaki,Hagino Hiroshi,Sone Teruki,Ohishi Hiroaki,Fujimoto Tsukasa,Sasaki Emma,Tanaka Sakae,Sugimoto Toshitsugu
Funder
Takeda Pharmaceutical Company
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism
Reference36 articles.
1. Das S, Crockett JC (2013) Osteoporosis—a current view of pharmacological prevention and treatment. Drug Des Dev Ther 7:435–448
2. Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Booth MJ, Motala A, Shekelle PG (2014) Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med 161:711–723
3. Goldshtein I, Rouach V, Shamir-Stein N, Yu J, Chodick G (2016) Role of side effects, physician involvement, and patient perception in non-adherence with oral bisphosphonates. Adv Ther 33:1374–1384
4. Mitchell DY, Heise MA, Pallone KA, Clay ME, Nesbitt JD, Russell DA, Melson CW (1999) The effect of dosing regimen on the pharmacokinetics of risedronate. Br J Clin Pharmacol 48:536–542
5. Warner Chilcott Company LLC (2015) ACTONEL® (risedronate sodium) tablets, United States prescribing information.
http://www.allergan.com/assets/pdf/actonel_pi
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献